Our current study investigated the mechanism of the inhibitory effect of berberin on CRC invasion and metastasis, and revealed a significant role of JAK2/STAT3 and COX-2/PGE2 signaling in these processes. The gene discussed is JAK2; the disease is colorectal carcinoma.